Prioritising patient-centred care in the management of chronic urticaria in Asia-Pacific countries

IF 3.9 2区医学 Q2 ALLERGY

World Allergy Organization Journal Pub Date : 2024-11-01 DOI:10.1016/j.waojou.2024.100984

Marysia Tiongco-Recto MD , Kent Woo MD , Wen-Hung Chung MD PhD , Gilbert T. Chua MBBS , Kiran Godse MD PhD , Ma Teresita Gabriel MD , Alexander Headley MBBS , Irene Lee Chew Kek MBBS , Kanokvalai Kulthanan MD , Mongkol Lao-Araya MD , Liwen Ma MD , Le Huyen My MD PhD , Siriwan Wananukul MD , Dinesh Nagrale MD

{"title":"Prioritising patient-centred care in the management of chronic urticaria in Asia-Pacific countries","authors":"Marysia Tiongco-Recto MD , Kent Woo MD , Wen-Hung Chung MD PhD , Gilbert T. Chua MBBS , Kiran Godse MD PhD , Ma Teresita Gabriel MD , Alexander Headley MBBS , Irene Lee Chew Kek MBBS , Kanokvalai Kulthanan MD , Mongkol Lao-Araya MD , Liwen Ma MD , Le Huyen My MD PhD , Siriwan Wananukul MD , Dinesh Nagrale MD","doi":"10.1016/j.waojou.2024.100984","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic urticaria (CU), in both inducible and spontaneous forms, is associated with a substantial burden in the Asia-Pacific region (APAC). Patient-centred care recognises patients desire to be involved in decisions regarding their health. Although patient-centred approaches have previously not been studied in the context of CU management, they have demonstrated benefits in the management of other chronic conditions.</div></div><div><h3>Methods</h3><div>Information and opinions regarding the barriers and solutions to the implementation of patient-centred approaches to the management of CU were gathered from a group of 13 expert dermatologists and allergist/immunologists from APAC through surveys and a face-to-face meeting.</div></div><div><h3>Results</h3><div>Barriers identified there included a lack of awareness of CU amongst patients, delays in consulting healthcare providers, financial constraints, and low adherence. Particular issues raised included a lack of suitable online information for patients (83% of experts), and patients accessing oral corticosteroids without a prescription. Compliance issues were also identified as key reasons for inadequate responses to treatments (67% of experts). Solutions proposed by the authors were improving patients' knowledge about their condition (92% strongly agree, 8% agree), physicians’ consideration of patient characteristics when choosing treatments (92% strongly agree, 8% agree), implementing shared decision-making (85% strongly agree, 15% agree), and using patient-reported outcome measures (70% strongly agree, 23% agree).</div></div><div><h3>Conclusion</h3><div>Expert opinion within APAC supports the use of patient-centred approaches to improve the management of <span>CU</span>. We provide several recommendations focusing on patient education and involvement in disease management as well as disease monitoring methods that can be implemented by physicians in APAC.</div></div>","PeriodicalId":54295,"journal":{"name":"World Allergy Organization Journal","volume":"17 11","pages":"Article 100984"},"PeriodicalIF":3.9000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Allergy Organization Journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1939455124001169","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Chronic urticaria (CU), in both inducible and spontaneous forms, is associated with a substantial burden in the Asia-Pacific region (APAC). Patient-centred care recognises patients desire to be involved in decisions regarding their health. Although patient-centred approaches have previously not been studied in the context of CU management, they have demonstrated benefits in the management of other chronic conditions.

Methods

Information and opinions regarding the barriers and solutions to the implementation of patient-centred approaches to the management of CU were gathered from a group of 13 expert dermatologists and allergist/immunologists from APAC through surveys and a face-to-face meeting.

Results

Barriers identified there included a lack of awareness of CU amongst patients, delays in consulting healthcare providers, financial constraints, and low adherence. Particular issues raised included a lack of suitable online information for patients (83% of experts), and patients accessing oral corticosteroids without a prescription. Compliance issues were also identified as key reasons for inadequate responses to treatments (67% of experts). Solutions proposed by the authors were improving patients' knowledge about their condition (92% strongly agree, 8% agree), physicians’ consideration of patient characteristics when choosing treatments (92% strongly agree, 8% agree), implementing shared decision-making (85% strongly agree, 15% agree), and using patient-reported outcome measures (70% strongly agree, 23% agree).

Conclusion

Expert opinion within APAC supports the use of patient-centred approaches to improve the management of CU. We provide several recommendations focusing on patient education and involvement in disease management as well as disease monitoring methods that can be implemented by physicians in APAC.

查看原文本刊更多论文

在亚太地区慢性荨麻疹的治疗中优先考虑以患者为中心的护理方法

背景慢性荨麻疹（CU），包括诱发性和自发性两种形式，在亚太地区（APAC）造成了巨大的负担。以患者为中心的医疗服务承认患者希望参与有关其健康的决策。方法通过调查和面对面会议的形式，从亚太地区的 13 位皮肤科专家和过敏/免疫科专家那里收集了有关实施以患者为中心的方法来管理 CU 的障碍和解决方案的信息和意见。提出的具体问题包括缺乏适合患者的在线信息（83% 的专家），以及患者在没有处方的情况下获得口服皮质类固醇。依从性问题也被认为是治疗效果不佳的主要原因（67% 的专家）。作者提出的解决方案包括提高患者对自身病情的了解（92%非常同意，8%同意），医生在选择治疗方法时考虑患者的特点（92%非常同意，8%同意），实施共同决策（85%非常同意，15%同意），以及使用患者报告的结果测量（70%非常同意，23%同意）。我们提供了几项建议，重点是患者教育和参与疾病管理以及疾病监测方法，可供亚太地区的医生实施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World Allergy Organization Journal Immunology and Microbiology-Immunology

CiteScore

9.10

自引率

5.90%

发文量

审稿时长

9 weeks

期刊介绍： The official pubication of the World Allergy Organization, the World Allergy Organization Journal (WAOjournal) publishes original mechanistic, translational, and clinical research on the topics of allergy, asthma, anaphylaxis, and clincial immunology, as well as reviews, guidelines, and position papers that contribute to the improvement of patient care. WAOjournal publishes research on the growth of allergy prevalence within the scope of single countries, country comparisons, and practical global issues and regulations, or threats to the allergy specialty. The Journal invites the submissions of all authors interested in publishing on current global problems in allergy, asthma, anaphylaxis, and immunology. Of particular interest are the immunological consequences of climate change and the subsequent systematic transformations in food habits and their consequences for the allergy/immunology discipline.